The Relative Strength (RS) Rating for Elevance Health jumped into a higher percentile Wednesday, as it got a lift from 64 to 72.
This exclusive rating from Investor's Business Daily measures market leadership with a 1 (worst) to 99 (best) score. The score shows how a stock's price movement over the last 52 weeks holds up against all the other stocks in our database.
Over 100 years of market history reveals that the best stocks often have an RS Rating north of 80 in the early stages of their moves. See if Elevance Health can continue to rebound and hit that benchmark.
Can You Really Time The Stock Market?
Elevance Health is not currently near a potential buy zone. See if the stock goes on to build a sound pattern that could spark a new run.
Earnings growth slowed last quarter from -7% to -32%. But revenue gains moved higher, from 5% to 7%. Keep an eye out for the company's next round of numbers on or around Apr. 22.
Elevance Health earns the No. 7 rank among its peers in the Medical-Managed Care industry group. Molina Healthcare, UnitedHealth Group and Cigna Group are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Stocks With Rising Relative Strength Ratings
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
